GALT Historical Earnings image   This GALT historical earnings page last updated 5/21/2024
GALT Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20245/15/2024NA
Q4 20233/29/2024NA
Q3 202311/13/2023NA
Q2 20238/14/2023NA
Q1 20235/15/2023NA
Q4 20223/30/2023NA
Q3 202211/14/2022NA
Q2 20228/15/2022NA
Q1 20225/16/2022NA
Q4 20213/31/2022NA
Q3 202111/15/2021NA
Q2 20218/16/2021NA
Q1 20215/17/2021NA
Q4 20203/31/2021NA
Q3 202011/9/2020NA
Q2 20208/10/2020NA
Q1 20205/11/2020NA
Q4 20193/16/2020NA
Q3 201911/12/2019NA
Q2 20198/9/2019NA
Q1 20195/10/2019NA
Q4 20183/6/2019NA
Q3 201811/13/2018NA
Q2 20188/14/2018NA
Q1 20185/11/2018NA
Q4 20173/29/2018NA
Q3 201711/7/2017NA
Q2 20178/14/2017NA
Q1 20175/15/2017NA
Q4 20163/28/2017NA
Q3 201611/8/2016NA
Q2 20168/9/2016NA
Q1 20165/10/2016NA
Q4 20153/15/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/11/2015NA
Q4 20143/18/2015NA
Q3 201411/10/2014NA
Q2 20148/7/2014NA
Q1 20145/13/2014NA
FY 20133/21/2014NA
Q3 201311/12/2013NA
Q2 20138/14/2013NA
Q1 20135/10/2013NA
Q4 20123/29/2013NA
Q3 201211/9/2012NA
GALT Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q1 20245/15/2024-0.190
Q4 20233/29/2024-0.160
Q3 202311/13/2023-0.240
Q2 20238/14/2023-0.150
Q1 20235/15/2023-0.190
Q4 20223/30/2023-0.180
Q3 202211/14/2022-0.140
Q2 20228/15/2022-0.160
Q1 20225/16/2022-0.170
Q4 20213/31/2022-0.120
Q3 202111/15/2021-0.140
Q2 20218/16/2021-0.140
Q1 20215/17/2021-0.110
Q4 20203/31/2021-0.130
Q3 202011/9/2020-0.100
Q2 20208/10/2020-0.110
Q1 20205/11/2020-0.060
Q4 20193/16/2020-0.120
Q3 201911/12/2019-0.050
Q2 20198/9/2019-0.060
Q1 20195/10/2019-0.200
Q4 20183/6/2019-0.08
Q3 201811/13/2018-0.07
Q2 20188/14/2018-0.11
Q1 20185/11/2018-0.12
Q4 20173/29/2018-0.07
Q3 201711/7/2017-0.13
Q2 20178/14/2017-0.14
Q1 20175/15/2017-0.15
Q4 20163/28/2017-0.12
Q3 201611/8/2016-0.19
Q2 20168/9/2016-0.2
Q1 20165/10/2016-0.24
Q4 20153/15/2016-0.19
Q3 201511/9/2015-0.26
Q2 20158/10/2015-0.21
Q1 20155/11/2015-0.22
Q4 20143/18/2015-0.18
Q3 201411/10/2014-0.17
Q2 20148/7/2014-0.17
Q1 20145/13/2014-0.27
FY 20133/21/2014-1.3
Q3 201311/12/2013-0.22
Q2 20138/14/2013-0.72
Q1 20135/10/2013-0.21
Q4 20123/29/2013-0.170
Q3 201211/9/2012-0.19
Quotes delayed 20 minutes

Email EnvelopeFree GALT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Galectin Therapeutics (GALT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

GBIO Historical Earnings
GBT Historical Earnings
GEHC Historical Earnings
GERN Historical Earnings
GH Historical Earnings
GILD Historical Earnings
GKOS Historical Earnings
GLSI Historical Earnings
GLUE Historical Earnings
GLYC Historical Earnings
What was the record high GALT historical earnings result?
In terms of earnings or revenue, what is the best GALT historical earnings result that Galectin Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest GALT historical earnings result was set in Q3 2019, when Galectin Therapeutics posted results of -0.050/share. The most successful revenue quarter within our data set was Q1 2024 when Galectin Therapeutics reported revenue of NA.

What was the lowest Galectin Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest GALT has reported, and when?

✔️Accepted answer: Within our data set, the lowest GALT historical earnings result was set in FY 2013, when Galectin Therapeutics posted results of -1.3/share. The smallest revenue quarter within our data set was Q1 2024 when Galectin Therapeutics reported revenue of NA.

On this page we presented the GALT historical earnings date information for Galectin Therapeutics. Reviewing that GALT Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2019, when GALT posted gaap of -0.050/share. Meanwhile the lowest GALT historical earnings result was in FY 2013, when GALT posted gaap of -1.3/share. Moving to Galectin Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q1 2024 when GALT reported NA in revenue, while the smallest revenue quarter was Q1 2024 when GALT reported NA in revenue.

For self directed investors doing their due diligence on GALT or any other given stock, their research can benefit from looking into all of the Galectin Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Galectin Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for GALT. Thanks for visiting, and the next time you need to research GALT historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: KMPH Options Chain, CLBT Options Chain, Funds Holding XP.


GALT Historical Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.